iCHIP® Platform

ImmunArray’s iCHIP® technology mines the information stored in the immune system repertoires in order to shed light on an individual’s specific immune profile.

Learn More

iCHIP intensity


SLE-key® is a molecular diagnostic test developed by ImmunArray to support a physician’s ability to rule-out a diagnosis of Systemic Lupus Erythematosus (SLE).

Learn More

TBI Program

Immunarray® is developing a series of assays and multiplex tests to assist in the diagnosis and prognosis of Brain Injury, in both acute (TBI) and chronic phases.

Learn More

See Us At

ACR/ARHP Annual Meeting 2016

November 11 – November 16, 2016, Washington, DC, USA

Poster Title: Autoantibody Reactivities Correlated with SLE Disease Activity Identified by the SLE-key® iCHIP® Platform

Authors: Putterman C, Safer P, Jakobi K, Sorek R, Gilkaite I, Ferber K, Wallace S, Harris Altice A, Batty D.S, Cohen I.R.

Read More

Recent News & Events

Quanterix and ImmunArray Teaming Up to Address Neurodegenerative Disease

Quanterix gains access to ImmunArray brain injury biomarker portfolio and ImmunArray gains access to Quanterix state of the art digital biomarker technology

Read More

Talk to Us


We are a clinically driven company guided by leadership physician input at each stage of our development. We welcome questions and open discussions, and look forward to continuing to work with our collaborators and partners around the globe.

Read More